SINGAPORE (Aug 13): Hyphens Pharma International reported 2Q19 earnings of $1.6 million, up 1.4% from $1.61 million for the same quarter last year.
Earnings per share for 2Q19 fell to 0.54 cent from 0.63 cent in 2Q18.
Group revenue for the quarter fell 6.1% to $29 million from $30.9 million the preceding year, due primarily to a decline of 14.1% in the specialty pharma principals segment in 2Q19 on the back of higher demand in 2Q18, ahead of products licensing renewal in Vietnam.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
